Impact of hepatic lymph node metastasis on survival of patients with synchronous resectable or unresectable liver metastases of colorectal cancer

Techniques in Coloproctology

Volumn 17, Issue 1, 2013, Pages 51-57

  Ishibashi, K ^a   Ishida, H ^a   Ohsawa, T ^a   Okada, N ^a   Kumamoto, K ^a   Haga, N ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Hepatic lymph node; Liver metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; INOPERABLE CANCER; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; COLORECTAL TUMOR; KAPLAN MEIER METHOD; LIVER RESECTION; LIVER TUMOR; LYMPH NODE; LYMPH NODE DISSECTION; METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; TIME; TUMOR INVASION; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84884497766     PISSN: 11236337     EISSN: 1128045X     Source Type: Journal    
DOI: 10.1007/s10151-012-0881-y     Document Type: Article

References (18)

1. Rodgers MS, McCall JL (2000) Surgery for colorectal liver metastases with hepatic lymph node involvement: a systematic review. Br J Surg 87:1142-1155
2. Giacchetti S, Itzhaki M, Gruia G et al (1999) Long-term survival of patients with unresectable colorectal liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10:663-669
3. Alberts SR, Horvath WL, Sternfeld WC et al (2005) Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liveronly metastases from colorectal cancer: a North Central Cancer treatment Group phase II study. J Clin Oncol 23:9243-9249
4. Adam R, Delvart V, Pascal G et al (2004) Rescue surgery for unresectable colorectal colorectal liver metastases downstaged by chemotherapy: a model to npredict long-term survival. Ann Surg 240:644-657
5. Delaunoit T, Alberts SR, Sargent DJ et al (2008) Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9471. Ann Oncol 16:626-637
6. Pozzo C, Basso M, Cassano A et al (2004) Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folic acid in colorectal cancer patients. Ann Oncol 15:933-939
7. Japanese Society for Cancer of the Colon and Rectum (2009) Japanese classification of colorectal carcinoma, 2nd English ed. Kanehara, Tokyo
8. Trutmann M, Sasse D (1994) The lymphatics of the liver. Anat Enbryol 190:201-209
9. Japanese Society of Biliary Surgery (2001) Classification of biliary tract carcinoma, 2nd English ed. Kanehara, Tokyo
10. Arai Y, Inaba Y, Takeuchi Y, Ariyoshi Y (1997) Intermittent hepatic arterial infusion of 5-FU on a weekly schedule for liver metastases from colorectal cancer. Cancer Chemother Pharmacol 40:526-530
11. Sobin LH, Gospodarowicz M, Wittelkind C (International Union Against Cancer) (2010) TNM classification of malignant tumors, 7th edn. Wiley-Backwell, New York, pp 100-105
12. Yamamura T, Tshukikawa S, Akaishi O et al (1997) Multivariate analysis of the prognostic factors of patients with unresectable synchronous liver metastases from colorectal cancer. Dis Colon Rectum 40:1425-1429
13. Hotta T, Takifuji K, Uchiyama K et al (2006) Potential predictors of survival after surgery for colorectal cancer patients with synchronous unresectable liver metastases. Oncol Rep 16:1369-1374
14. August DA, Sugarbaker PH, Scneider PD (1985) Lymphatic dissemination of hepatic metastases. Implications for the followup and treatment of patients with colorectal cancer. Cancer 55:1490-1494
15. Watanabe T, Itabashi M, Shimada Y et al (2012) Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Oncol 17:1-29
16. Lehmann K, Rickenbacher A, Weber A, Pestalozzi BC, Clavien PA (2012) Chemotherapy before liver resection of colorectal metastases. Friend or foe? Ann Surg 255:237-247
17. Nordlinger B, Sorbye H, Glimelius B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EOTTC Intergroup trial 40983): a randomized controlled trial. Lancet 371:1007-1016
18. Pulitanò C, Bodingbauer M, Aldrighetti L et al (2012) Colorectal liver metastasis in the setting of lymph node metastasis: defining the benefit of surgical resection. Ann Surg Oncol 19:435-442